Here are four key notes:
1. Under the Offering, the company issued 2.53 million common shares at a price of $0.15 per share for aggregate gross proceeds of $385,443.
2. Aurora Spine will use the offering’s proceeds for general working capital purposes.
3. The common shares issued under the offering are subject to a four-month hold period that expires October 1, 2016, pursuant to Canadian securities laws.
4. The offering is subject to certain conditions, including the receipt of all necessary approvals, such as final approval of the TSX Venture Exchange.
More articles on devices:
33 organizations implore Congress to postpone CMS equipment proposal: 5 things to know
Simplifying orthopedics in a complex industry — Dr. Joe Kohli changes the game with [m]pirik
InVivo Therapeutics shares mission on radio broadcast — 3 notes
